General Announcement::GPL Announces New Data Presentations on Ryaltris at the ACAAI Annual Scientific Meeting 2018

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
16-Nov-2018 18:36:40
Status
New
Announcement Sub Title
GPL Announces New Data Presentations on Ryaltris at the ACAAI Annual Scientific Meeting 2018
Announcement Reference
SG181116OTHRLSXS
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
16/11/2018 16:04:00
Description (Please provide a detailed description of the event in the box below)
Sub: Glenmark Pharmaceuticals Announces New Data Presentations on Ryaltris at the ACAAI Annual Scientific Meeting 2018

With reference to the subject mentioned above, kindly find attached media release which is self-explanatory.

Request you to kindly take the same on record.


Attachments

SGX_PR_1611.pdf
Total size =230K